Trial intelligence / Profile preview

Sublingual Buprenorphine vs Morphine Sulfate for NAS

NCT01708707Phase 2Completed

Sponsor
Pediatrix Medical Group
Start
Dec 2012
Primary completion
Oct 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of buprenorphine in neonatal abstinence syndrome (NAS), sponsored by Pediatrix Medical Group. Started Dec 2012; status: completed.

02

Drugs

buprenorphine
03

Conditions

neonatal abstinence syndrome (NAS)

Beyond the preview

Go deeper on NCT01708707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01708707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call